Sinking stock threatens Atossa's place on the Nasdaq

Published on 11 Oct 2022 on American City Business Journals

Seattle-based biotech Atossa Therapeutics Inc. (Nasdaq: ATOS) faces delisting from the Nasdaq because its share price has dipped below ...

Read the rest of the article

Start tracking your investments with Statfolio

Net Loss: Reported a net loss of $7.0 million for Q1 2024, slightly above the estimated net loss ...

GuruFocus.com via Yahoo Finance 15 May 2024

Atossa Therapeutics, Inc. ATOS recently announced promising safety and efficacy data from the com...

Zacks via Yahoo Finance 11 Apr 2024

Atossa Therapeutics Inc (NASDAQ:ATOS) shares continued to move higher on Wednesday, buoyed by the...

Proactive Investors 20 Mar 2024

Seattle-based biotech Atossa Therapeutics Inc. (Nasdaq: ATOS) has regained compliance with Nasdaq...

The Business Journals 19 Mar 2024

Atossa Therapeutics Inc (NASDAQ:ATOS), a company specializing in developing pharmaceuticals, has...

Proactive Investors 19 Mar 2024

Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company, announced...

Investing.com 19 Mar 2024

We feel now is a pretty good time to analyse Atossa Therapeutics, Inc.'s (NASDAQ:ATOS) business a...

Simply Wall St. via Yahoo Finance 24 Jan 2024

In this article we present the list of 10 Best Debt Free Penny Stocks To Buy Now. Click to skip o...

Insider Monkey via Yahoo Finance 4 Dec 2023

Typically, penny stocks are pure market wages for hardened gamblers. In fact, penny stocks are al...

InvestorPlace via Yahoo Finance 2 Apr 2023

Seattle-based biotech Atossa Therapeutics Inc. (Nasdaq: ATOS) faces delisting from the Nasdaq bec...

American City Business Journals 11 Oct 2022